Attached files
file | filename |
---|---|
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - AzurRx BioPharma, Inc. | ex31-1.htm |
10-K - FORM 10-K - AzurRx BioPharma, Inc. | azrx10k_dec312016.htm |
DRAFT
|
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of AzurRx
BioPharma, Inc. (the “Company”) on Form 10-K for the fiscal year ended
December 31, 2016 as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), I, Johan M. (Thijs) Spoor, Chief
Executive Officer and Principal Financial Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002,
that:
|
(1) The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934;
and
|
|
(2) The information contained in the Report fairly presents,
in all material respects, the financial condition and results of
operations of the Company.
|
Date: March 31, 2017
|
/s/
Johan M. (Thijs)
Spoor
|
|
Johan M. (Thijs) Spoor
President and Chief Executive Officer
(Principal Executive and Financial Officer)
|
|
|